Elizabeth Novick, MD

home / authors / elizabeth-novick-md-and-rebecca-moon

Novick is an infectious diseases physician at Thomas Jefferson University Hospital, where she also serves as associate program director of the infectious diseases fellowship.

Articles

Tuberculosis Meningitis in an Immunocompetent Patient

Tuberculosis Meningitis in an Immunocompetent Patient

Laura Walters, DO;Elizabeth Braden, MD;Elizabeth Novick, MD;Nikita Jaggernauth, MD
November 12th 2024

Read more about the case of a 71-year-old man who was admitted after presenting with cold-like symptoms for 3 weeks.

Read More

Mixed Fungal Brain Abscess

Mixed Fungal Brain Abscess

Joseph Glowacki, DO;Devin Weber, MD;Dagan Coppock, MD;Elizabeth Novick, MD;Mollie Tucker, MD
April 1st 2024

Clinicians review a patient case including diagnosis, treatment, and follow-up.

Read More

A Case of Pneumonia and Bacteremia in a Trauma Patient Caused by Bordetella hinzii

A Case of Pneumonia and Bacteremia in a Trauma Patient Caused by Bordetella hinzii

Elizabeth Novick, MD
December 28th 2020

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
STAY PrEPARED: Understanding COVID-19 Pre-Exposure Prophylaxis
Published: November 10th 2024 | Updated: November 21st 2024
STAY PrEPARED: Understanding COVID-19 Pre-Exposure Prophylaxis
Echinocandin Dosing Considerations in Obese Patients: A Review
Published: November 18th 2024 | Updated: November 18th 2024
Echinocandin Dosing Considerations in Obese Patients: A Review
More Women Than Men Die After Staph Bacteremia
Published: November 17th 2024 | Updated: November 21st 2024
More Women Than Men Die After Staph Bacteremia
Considerations for Discharge
Published: November 14th 2024 | Updated: November 21st 2024
Considerations for Discharge
Efficacy of 8-Week Daclatasvir-Sofosbuvir Regimen for Chronic Hepatitis C
Published: November 13th 2024 | Updated: November 21st 2024
Efficacy of 8-Week Daclatasvir-Sofosbuvir Regimen for Chronic Hepatitis C
© 2024 MJH Life Sciences

All rights reserved.